Antimetabolites: all 7,305 studies that test it
Page 57 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- TaxXel: Taxotere and Xeloda in Esophageal CancerStatus unknownNCT00821912Phase 1/2
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)Status unknownNCT00817583Phase 2
- A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of LungCompletedNCT00816868Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal CarcinomaStatus unknownNCT00816855Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal CarcinomaStatus unknownNCT00816816Phase 2
- Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)Status unknownNCT00815568Phase 2
- A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast CancerCompletedNCT00813956Phase 2
- Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)CompletedNCT00812864Phase 4
- CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7CompletedNCT00812669Phase 2
- Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT00809172Phase 3
- Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia IntermediaCompletedNCT00809042Phase 2
- Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT00808145Phase 2
- Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination ChemotherapyStatus unknownNCT00807261Phase 2
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2
- Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00805012Phase 2
- Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to TreatmentCompletedNCT00802568Phase 2
- Leflunomide Associated With Topical Corticosteroids for Bullous PemphigoidStatus unknownNCT00802243Phase 2
- Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)WithdrawnNCT00800566Phase 1
- Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentTerminatedNCT00800150Phase 1
- Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic LeukemiaCompletedNCT00795756Phase 2/3
- Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell TransplantationCompletedNCT00795548Phase 2
- A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without CetuximabStatus unknownNCT00795301Phase 2
- Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan VolunteersCompletedNCT00791531Phase 1
- Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I PortionTerminatedNCT00791271Phase 1
- Haploidentical Stem Cell Transplantation in NeuroblastomaStatus unknownNCT00790413Early Phase 1
- Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNCT00789763Phase 1
- Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or LymphomasCompletedNCT00788099Phase 1
- Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00787969Phase 1
- Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid CancerStatus unknownNCT00786552Phase 2
- Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLCStatus unknownNCT00786331Phase 2
- A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNCT00783536Phase 4
- Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic CancerTerminatedNCT00783172Phase 1
- Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical CancerTerminatedNCT00782041Phase 2
- Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTICStatus unknownNCT00779714Phase 3
- Combined Biological Treatment and Chemotherapy for Patients With Inoperable CholangiocarcinomaCompletedNCT00779454Phase 2
- A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid TumourCompletedNCT00778128Phase 1
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00769522Phase 3
- FAU in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00769288Phase 1
- Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT00766480Not applicable
- Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT00764907Phase 3
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple MyelomaCompletedNCT00761722Phase 1
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid ArthritisCompletedNCT00760864Phase 2
- Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal CancerCompletedNCT00759226Phase 2
- "Steroids and Azathioprine Versus Steroids Alone in IgAN"CompletedNCT00755859Phase 4
- Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcTerminatedNCT00755118Phase 2
- Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly PatientsTerminatedNCT00754364Phase 2
- Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast CancerCompletedNCT00754351Phase 2
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- Phase I Study of TAS-106 in Combo With CarboplatinCompletedNCT00752011Phase 1
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 2
- A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)TerminatedNCT00750334Phase 1
- Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT00750126Phase 2
- Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal CancerCompletedNCT00749450Phase 3
- Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00748527Phase 2
- Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT00747799Phase 2
- Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II StudyCompletedNCT00747097Phase 2
- Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)CompletedNCT00744900Phase 2
- Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic CarcinomaCompletedNCT00744640Phase 1/2
- Pemetrexed Plus Bevacizumab in Non Small Cell Lung CancerCompletedNCT00741221Phase 2
- Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive ChemotherapyCompletedNCT00739388Phase 2
- Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLLCompletedNCT00738829Phase 1/2
- Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung CancerCompletedNCT00737867Phase 3
- Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)Status unknownNCT00737685Phase 2
- First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00736814Phase 2
- Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSLWithdrawnNCT00734773Early Phase 1
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic CancerCompletedNCT00733850Phase 2
- Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General StatusCompletedNCT00733616Phase 2
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TerminatedNCT00733031Phase 1
- Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction TherapyStatus unknownNCT00728520Phase 2
- Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaWithdrawnNCT00728000Phase 2
- A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00727987Phase 3
- Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT00727831Phase 1/2
- Oral Clofarabine for Acute Myeloid LeukemiaCompletedNCT00727766Phase 1
- Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsTerminatedNCT00726687Phase 1
- Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric CancerCompletedNCT00718913Phase 2
- Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentTerminatedNCT00717990Phase 2
- A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast CancerStatus unknownNCT00717951Phase 2
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE StudyStatus unknownNCT00715637Phase 3
- 8-Chloro-Adenosine in Chronic Lymphocytic LeukemiaCompletedNCT00714103Phase 1
- Gemcitabine/Oxaliplatin and Photodynamic Therapy in CholangiocarcinomaWithdrawnNCT00713687Phase 2
- Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System LymphomaWithdrawnNCT00712062Phase 2
- Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive LeukemiaStatus unknownNCT00709215Phase 1/2
- Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas AdenocarcinomaCompletedNCT00707278Phase 1
- Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00707083Phase 3
- Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast CancerCompletedNCT00706069Phase 1
- Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
- Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)Status unknownNCT00704704Phase 2
- Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00703365Phase 2
- Decitabine and Bortezomib in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00703300Phase 1
- Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction CancerCompletedNCT00701857Phase 1
- Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00697905Phase 2
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantCompletedNCT00697684Phase 1
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
- Study of Capecitabine In Patients With Solid TumorsCompletedNCT00697502Phase 1
- Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder CancerCompletedNCT00696579Phase 1/2
- Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell CancerWithdrawnNCT00696007Phase 2
- The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsCompletedNCT00695994Phase 2
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal CancerCompletedNCT00695201Phase 1